At Biogen Idec, we can
be creative and feel
free to take risks.

SHA MI (MISHA), PhD.
Principal Investigator, Neurobiology

Misha discovered a molecule called LINGO which, when blocked, facilitates the regeneration of nerves. She is developing an anti-LINGO antibody that may revolutionize central nervous system treatment.

View all employee profiles

Biogen Idec

Vår visjon:

“Through excellence in all that we do, Biogen Idec will become the most effective and most admired company in the biopharmaceutical industry, providing meaningful benefits for patient and exceptional value for shareholders”.

Biogen Idec er et globalt, børsnotert bioteknologisk selskap med hovedkontor i USA. Vi har ca. 5.000 ansatte verden over. Det norske kontoret ligger i Oslo og har 14 ansatte.
 

I Norge markedsfører vi tre produkter mot MS.
 

Product Pipeline

Product Pipeline

Biogen Idec has one of the most impressive product pipelines in its class.

Explore the Pipeline